Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Tenembaum

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Movement Disorders Clinical Practice|March 7, 2019
Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG GeneMalco Rossi, Alex Medina Escobar, Martin Radrizzani, et al.
Neurology|August 31, 2016
Neuromyelitis optica spectrum disorders in children and adolescentsSilvia Tenembaum, Tanuja Chitnis, Ichiro Nakashima, et al.
Multiple Sclerosis and Related Disorders|October 8, 2023
Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based studyAndrés M Villa, Analisa Manin, Carla Seimandi, et al.
Pediatric Neurology|July 3, 2024
A Clinical Neurological Approach to the Child With Adenosine Deaminase DeficiencyPaula Ivarola, Luciano Urdinez, Matias Oleastro, et al.
Acta Haematologica|March 22, 2006
Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registryMariana Bonduel, Gabriela Sciuccati, Mirta Hepner, et al.
Journal of the Neurological Sciences|March 23, 2016
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective studyLauren B Krupp, Daniela Pohl, Angelo Ghezzi, et al.
Neurology|August 31, 2016
Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndromeDaniela Pohl, Gulay Alper, Keith Van Haren, et al.
The Lancet. Child & Adolescent Health|August 7, 2025
Access to therapy for children and adolescents with multiple sclerosis: global considerations in preventing disease progressionE Ann Yeh, Helen Tremlett, Rabporn Suntornlohanakul, et al.
Neurology|May 3, 2019
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSGEmmanuelle Waubant, Brenda Banwell, Evangeline Wassmer, et al.
Neurology|October 25, 2019
Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelinationAndrea Savransky, Adrian Rubstein, Marina Huaman Rios, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Movement Disorders Clinical Practice|March 7, 2019
Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG GeneMalco Rossi, Alex Medina Escobar, Martin Radrizzani, et al.
Neurology|August 31, 2016
Neuromyelitis optica spectrum disorders in children and adolescentsSilvia Tenembaum, Tanuja Chitnis, Ichiro Nakashima, et al.
Multiple Sclerosis and Related Disorders|October 8, 2023
Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based studyAndrés M Villa, Analisa Manin, Carla Seimandi, et al.
Pediatric Neurology|July 3, 2024
A Clinical Neurological Approach to the Child With Adenosine Deaminase DeficiencyPaula Ivarola, Luciano Urdinez, Matias Oleastro, et al.
Acta Haematologica|March 22, 2006
Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registryMariana Bonduel, Gabriela Sciuccati, Mirta Hepner, et al.
Journal of the Neurological Sciences|March 23, 2016
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective studyLauren B Krupp, Daniela Pohl, Angelo Ghezzi, et al.
Neurology|August 31, 2016
Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndromeDaniela Pohl, Gulay Alper, Keith Van Haren, et al.
The Lancet. Child & Adolescent Health|August 7, 2025
Access to therapy for children and adolescents with multiple sclerosis: global considerations in preventing disease progressionE Ann Yeh, Helen Tremlett, Rabporn Suntornlohanakul, et al.
Neurology|May 3, 2019
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSGEmmanuelle Waubant, Brenda Banwell, Evangeline Wassmer, et al.
Neurology|October 25, 2019
Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelinationAndrea Savransky, Adrian Rubstein, Marina Huaman Rios, et al.
Pageof 4